APC anti-mouse NK-1.1 Antibody

Pricing & Availability
Clone
PK136 (See other available formats)
Regulatory Status
RUO
Other Names
NKR-P1C, NKR-P1B, Ly-55, CD161, CD161b, CD161c
Isotype
Mouse IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
PK136_APC_1_110210
C57BL/6 mouse splenocytes were stained with CD49b (DX5) FITC and NK1.1 (clone PK136) APC (top) or mouse IgG2a APC isotype control (bottom).
  • PK136_APC_1_110210
    C57BL/6 mouse splenocytes were stained with CD49b (DX5) FITC and NK1.1 (clone PK136) APC (top) or mouse IgG2a APC isotype control (bottom).
  • PK136_APC_2_110210
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
108709 25 µg £61
Check Availability


Need larger quantities of this item?
Request Bulk Quote
108710 100 µg £200
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
NK-1+ cells from mouse spleen and bone marrow
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The NK-1.1 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, complement-dependent cytotoxicity3, in vivo depletion4,5,9,10, mediation of in vitro redirected lysis6, blocking of NK cell function7, induction of proliferation8, immunohistochemical staining of frozen sections11, immunofluorescence microscopy11, and spatial biology (IBEX)16,17. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 108712).

Application References

(PubMed link indicates BioLegend citation)
  1. Carlyle JR, et al. 1999. J. Immunol. 162:5917. (IP)
  2. Sentman CL, et al. 1989. Hybridoma 8:605. (IP)
  3. Koo GC, et al. 1984. Hybridoma 3:301. (Cyt)
  4. Sentman CL, et al. 1989. J. Immunol. 142:1847. (Deplete)
  5. Koo GC, et al. 1986. J. Immunol. 137:3742. (Deplete)
  6. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  7. Kung SK, et al. 1999. J. Immunol. 162:5876. (Block)
  8. Reichlin A, et al. 1998. Immunol. Cell Biol. 76:143.
  9. Drobyski W, et al. 1996. Blood 87:5355. (Deplete)
  10. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (Deplete)
  11. Kanwar JR, et al. 2001. J. Natl. Cancer Inst. 93:1541. (IHC, IF)
  12. Kroemer A, et al. 2008. J. Immunol. 180:7818. PubMed
  13. Kim JY, et al. 2009. Exp Mol Med. 30:288. PubMed
  14. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  15. Lee H, et al. 2014. Invest Ophthalmol Vis Sci. 55:2885. PubMed
  16. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  17. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  2. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  3. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  4. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  5. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  6. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  7. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  8. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  9. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  10. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  11. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  12. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  13. Shen T, et al. 2019. Cell Death Discov. 5:123. PubMed
  14. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  15. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  16. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  17. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  18. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  19. Sun SJ, et al. 2022. Commun Biol. 5:867. PubMed
  20. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  21. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  22. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  23. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  24. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  25. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  26. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  27. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  28. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  29. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  30. Janakiram N, et al. 2016. Sci Rep. 6:37046. PubMed
  31. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  32. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  33. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  34. Hirata Y, et al. 2015. PLoS One. 10: 0141785. PubMed
  35. Wei SC, et al. 2020. Cancer Discov. . PubMed
  36. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  37. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  38. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  39. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  40. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  41. Hernández–Santos N, et al. 2018. Cell Host Microbe. 1.313194444. PubMed
  42. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  43. Guo L, et al. 2021. Front Immunol. 12:785457. PubMed
  44. Zenker S, et al. 2014. J Immunol. 192:2830. PubMed
  45. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  46. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  47. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  48. Hutter K, et al. 2020. FEBS J. . PubMed
  49. Xu J et al. 2018. Cell. 173(3):762-775 . PubMed
  50. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  51. Textor A, et al. 2014. Cancer Res. 74:6769. PubMed
  52. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  53. Stotesbury C, et al. 2020. J Immunol. 204:1582. PubMed
  54. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  55. Bourque J, et al. 2021. Heliyon. 7:e08311. PubMed
  56. Kim S, et al. 2021. Elife. 10:. PubMed
  57. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  58. Lim S, et al. 2016. PLoS One. 11: 0155689. PubMed
  59. Solaymani-Mohammadi S, et al. 2016. J Leukoc Biol. 99: 475 - 482. PubMed
  60. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  61. Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed
  62. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  63. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  64. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  65. Terhorst D, et al. 2015. J Immunol. 195: 4953 - 4961. PubMed
  66. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  67. DiToro D, et al. 2020. Immunity. 650:52. PubMed
  68. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  69. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  70. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  71. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  72. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  73. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  74. Tsuzuki S, et al. 2015. Int Immunol. 10.1093/intimm/dxv058. PubMed
  75. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  76. Zhang H, et al. 2017. Immunol Cell Biol. 10.1038/icb.2017.11. PubMed
  77. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  78. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  79. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  80. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  81. Huang W, et al. 2014. J Leukoc Biol. 96:55. PubMed
  82. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  83. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  84. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  85. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  86. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  87. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  88. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  89. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  90. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  91. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  92. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  93. Liu CF, et al. 2017. Front Immunol. 1.445833333. PubMed
  94. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  95. Gawish R, et al. 2022. Elife. 11:. PubMed
  96. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  97. Schmidts A, et al. 2020. J Immunother Cancer. 8:. PubMed
  98. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
RRID
AB_313396 (BioLegend Cat. No. 108709)
AB_313397 (BioLegend Cat. No. 108710)

Antigen Details

Structure
NKR-P1 gene family
Distribution

NK and NK-T cells in the NK1.1 mouse strains (C57BL, FVB/N, NZB)

Function
NK cell activation, IFN-γ production, cytotoxic granule release
Cell Type
NK cells, NKT cells
Biology Area
Immunology, Innate Immunity
Antigen References

1. Lanier LL. 1997. Immunity 6:371.
2. Yokoyama WM, et al. 1993. Ann. Rev. Immunol. 11:613.
3. Koo GC, et al. 1986. J. Immunol. 137:3742.
4. Giorda R, et al. 1991. J. Immunol. 147:1701.

Gene ID
17059 View all products for this Gene ID
UniProt
View information about NK-1.1 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 12/08/2016

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse NK-1.1

  • Biotin anti-mouse NK-1.1

  • FITC anti-mouse NK-1.1

  • PE anti-mouse NK-1.1

  • Purified anti-mouse NK-1.1

  • PE/Cyanine7 anti-mouse NK-1.1

  • PE/Cyanine5 anti-mouse NK-1.1

  • Alexa Fluor® 488 anti-mouse NK-1.1

  • Alexa Fluor® 647 anti-mouse NK-1.1

  • Pacific Blue™ anti-mouse NK-1.1

  • Brilliant Violet 711™ anti-mouse NK-1.1

  • APC/Cyanine7 anti-mouse NK-1.1

  • PerCP anti-mouse NK-1.1

  • PerCP/Cyanine5.5 anti-mouse NK-1.1

  • Alexa Fluor® 700 anti-mouse NK-1.1

  • Brilliant Violet 421™ anti-mouse NK-1.1

  • Brilliant Violet 570™ anti-mouse NK-1.1

  • Brilliant Violet 650™ anti-mouse NK-1.1

  • Brilliant Violet 510™ anti-mouse NK-1.1

  • Brilliant Violet 605™ anti-mouse NK-1.1

  • Purified anti-mouse NK-1.1 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse NK-1.1

  • Brilliant Violet 785™ anti-mouse NK-1.1

  • APC/Fire™ 750 anti-mouse NK-1.1

  • TotalSeq™-A0118 anti-mouse NK-1.1

  • Ultra-LEAF™ Purified anti-mouse NK-1.1

  • TotalSeq™-B0118 anti-mouse NK-1.1

  • TotalSeq™-C0118 anti-mouse NK-1.1

  • PE/Fire™ 810 anti-mouse NK-1.1

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account